Grace Therapeutics

GRCENasdaq Canada Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$28.578 M

$2.13 +0.47%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$7.79M

Loss-making

Shares outstanding

16,274,026

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#375Lite StrategyLITS$30.9M
#376Kyntra BioKYNB$29.4M
#377Grace TherapeuticsGRCE$28.6M
#378Rockwell MedicalRMTI$28.2M
#379Universe PharmaceuticalsUPC$27.9M

Where these numbers come from

Share counts and financials for Grace Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.